Medartis Holding AG
MED | SW
Overview
Corporate Details
- ISIN(s):
- CH0386200239
- LEI:
- 506700VUSP6HG3F28846
- Country:
- Switzerland
- Address:
- Hochbergerstr. 60E, 4057 Basel
- Website:
- https://www.medartis.com/
- Sector:
- Health Care
- Industry:
- Health Care Equipment & Supplies
Description
As an innovation leader, Medartis promotes technologies and solutions for osteosynthesis in the fields of cranio-maxillofacial surgery as well as upper and lower extremities. In close cooperation with international surgeons and scientists from leading clinics and universities. Developed and produced at the headquarters in Basel/Switzerland. For optimized treatment and an improved quality of life for patients. Worldwide.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
Market Cap data is planned for a future update.
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Chat, Summarize & Extract with AI!
You have of free filing views remaining.
Upgrade for unlimited access.
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-03-19 06:59 |
Earnings Release
Medartis delivers 12% core sales growth in 2024 and improves its core EBITDA ma…
|
English | 54.2 KB | |
| 2025-03-18 06:59 |
Earnings Release
Medartis delivers 12% core sales growth in 2024 and improves its core EBITDA ma…
|
English | 54.2 KB | |
| 2025-03-18 01:00 |
Earnings Release
Medartis delivers 12% core sales growth in 2024 and improves its core EBITDA ma…
|
English | 61.8 KB | |
| 2025-03-18 01:00 |
Earnings Release
Medartis erzielt 2024 ein Kernumsatzwachstum von 12 % und verbessert ihre Kern-…
|
German | 63.2 KB | |
| 2024-08-20 07:05 |
Earnings Release
Medartis reports 13% revenue growth on Group level, driven by strong regional g…
|
English | 51.0 KB | |
| 2024-08-20 02:00 |
Earnings Release
Medartis reports 13% revenue growth on Group level, driven by strong regional g…
|
English | 45.2 KB | |
| 2024-08-20 02:00 |
Earnings Release
Medartis verzeichnet ein Umsatzwachstum von 13% auf Gruppenebene, angetrieben d…
|
German | 48.8 KB | |
| 2024-07-09 06:59 |
Board/Management Change
Basel, 9th July 2024
Matthias Schupp appointed as CEO of Medartis
|
English | 10.2 KB | |
| 2024-07-09 02:00 |
Board/Management Change
Basel, 9th July 2024
Matthias Schupp appointed as CEO of Medartis
|
English | 8.3 KB | |
| 2024-07-09 02:00 |
Board/Management Change
Basel, 9. Juli 2024
Matthias Schupp zum CEO von Medartis ernannt
|
German | 8.9 KB | |
| 2024-06-11 06:59 |
Board/Management Change
Basel, 11th June 2024
Medartis announces resignation of CEO Christoph Bronni…
|
English | 8.3 KB | |
| 2024-06-11 02:00 |
Board/Management Change
Basel, 11th June 2024
Medartis announces resignation of CEO Christoph Brönni…
|
English | 6.6 KB | |
| 2024-06-11 02:00 |
Board/Management Change
Basel, 11. Juni 2024
Medartis gibt den Rücktritt von CEO Christoph Brönniman…
|
German | 7.2 KB | |
| 2024-04-04 07:25 |
Capital/Financing Update
Medartis successfully places CHF 115.8 million convertible bonds due 2031
|
English | 19.1 KB | |
| 2024-04-04 02:00 |
Capital/Financing Update
Medartis successfully places CHF 115.8 million convertible bonds due 2031
|
English | 17.4 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-04-25 | N/A | Non-Executive member | Buy | None | 176,411.02 CHF |
| 2025-04-10 | N/A | Non-Executive member | Buy | None | 37,500.00 CHF |
| 2025-04-08 | N/A | Non-Executive member | Buy | None | 375,000.00 CHF |
| 2024-12-30 | N/A | Non-Executive member | Buy | None | 4,999,956.00 CHF |
| 2024-12-20 | N/A | Executive member | Buy | None | 5,120.00 CHF |
| 2024-12-19 | N/A | Executive member | Buy | None | 5,300.00 CHF |
| 2024-12-17 | N/A | Executive member | Buy | None | 16,200.00 CHF |
| 2024-12-16 | N/A | Executive member | Buy | None | 2,214.00 CHF |
| 2024-12-12 | N/A | Executive member | Buy | None | 1,188.00 CHF |
| 2024-12-11 | N/A | Executive member | Buy | None | 72,795.60 CHF |
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
Biocorp | France | ALCOR | |
|
BioLight Life Sciences Ltd. | Israel | BOLT | |
|
BioMaxima S.A. | Poland | BMX | |
|
bioMérieux | France | BIM | |
|
Bioretec Oy | Finland | BRETEC | |
|
Boule Diagnostics | Sweden | BOUL | |
|
BPC Instruments AB | Sweden | BPCINS | |
|
BrainCool AB | Sweden | BRAIN | |
|
CALEDONIAN TRUST PLC | United Kingdom | CNN | |
|
Careium AB | Sweden | CARE |